1. HBW Insight
  2. >>Health
  3. >>Policy & Regulation
  4. >>Regulation

First Final Guidance For Overhauled US OTC Monograph Program Covers Submitting Proposals

 
• By Malcolm Spicer

Publication of final guidance for industry on submitting change proposals and other requests using the only accepted format, electronic, leaves agency at four of the five required guidances it has provided on compliance with requirements of its streamlined OTC monograph process.

• Source: Shutterstock

It remains four down and one to go for guidances the US Food and Drug Administration is required to provide by the legislation authorizing its OTC monograph program overhaul as the first guidance is made final.

Publication on 23 July of the final guidance for industry on submitting change proposals and other requests using the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

Japan Approves OTC Sale Of Emergency Contraceptive Pill

 
• By David Ridley

Aska Pharmaceutical has recieved a green light from Japan’s Ministry of Health, Labour and Welfare for the Rx-to-OTC switch of its NorLevo (1.5mg levonorgestrel) emergency contraceptive. Controversially, OTC NorLevo will need to be taken on the spot by purchasers in the presence of a pharmacist.

Kennedy Suggestion For GRAS Change Grows Rapidly To Planned Date For Proposed Rule

 
• By Malcolm Spicer

Proposed rule to eliminate self-GRAS without submitting regulatory notification planned seven months after HHS Secretary Kennedy Jr. suggested change. Latest HHS regulatory agenda also includes publication of FDA final rule to deem supplements unapproved drugs when co-packaged with drugs.

Former DoJ Antitrust Prosecutor Moves To FTC As Competition Bureau Health Care Division Chief

 
• By Malcolm Spicer

Emma Mittelstaedt Burnham prosecuted antitrust violations in healthcare sector in her previous work at DoJ, including leading investigation into antitrust cartels in the generic pharmaceutical industry.

MAHA Healthy Children Strategy Report Likely To Claim Link Between Acetaminophen And Autism

 
• By Malcolm Spicer

MAHA meeting announcement followed reports that HHS Secretary Robert F. Kennedy Jr. planned in September to release report on potential link to autism from pregnant women’s use of OTC acetaminophen.

More from Policy & Regulation

MAHA Commission’s Healthy Children Strategy Report Fails Supplement Industry’s Assessment

 
• By Malcolm Spicer

To supplement industry, MAHA’s “Make Our Children Healthy Again” Strategy Report stands out more for what it doesn’t say than what it does. Another omission is anything about HHS Secretary Kennedy’s focus on potential link between pregnant women’s use of acetaminophen and children's autism.

MAHA Healthy Children Strategy Report Likely To Claim Link Between Acetaminophen And Autism

 
• By Malcolm Spicer

MAHA meeting announcement followed reports that HHS Secretary Robert F. Kennedy Jr. planned in September to release report on potential link to autism from pregnant women’s use of OTC acetaminophen.

Oura Gets Smart Ring Competitors Banned From US, But Faces Ultrahuman Countersuit

 
• By Elizabeth Orr

The US International Trade Commission has banned smart rings from Ultrahuman and RingConn after Oura Health's patent infringement case. Ultrahuman countersued, claiming Oura infringes its intellectual property. Sales and marketing of the affected rings will cease on October 22.